What Tenaya Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 8 | 35 |
| Total trades | 10 | 40 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 171,000 | 407,600 |
| Disposed | 29,656 | 9,468,803 |
| Net activity | +141,344 | −9,061,203 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer | Sep 10 | Grant / award · A | +49,000 | — | — | 263,073 |
| Ali Faraz | Chief Executive Officer | Sep 10 | Grant / award · A | +122,000 | — | — | 539,782 |
| Tingley Whittemore | Chief Medical Officer | Aug 17 | Open-market sale · S | −2,279 | $0.71 | −$1.62K | 214,073 |
| Tingley Whittemore | Chief Medical Officer | Aug 17 | Open-market sale · S | −1,871 | $0.71 | −$1.33K | 216,352 |
| Tingley Whittemore | Chief Medical Officer | Aug 17 | Open-market sale · S | −1,637 | $0.71 | −$1.16K | 218,223 |
| Tingley Whittemore | Chief Medical Officer | Aug 17 | Open-market sale · S | −1,637 | $0.71 | −$1.16K | 219,860 |
| Ali Faraz | Chief Executive Officer | Aug 17 | Open-market sale · S | −7,406 | $0.71 | −$5.26K | 417,782 |
| Ali Faraz | Chief Executive Officer | Aug 17 | Open-market sale · S | −5,020 | $0.71 | −$3.56K | 425,188 |
| Ali Faraz | Chief Executive Officer | Aug 17 | Open-market sale · S | −3,969 | $0.71 | −$2.82K | 430,208 |
| Ali Faraz | Chief Executive Officer | Aug 17 | Open-market sale · S | −5,837 | $0.71 | −$4.14K | 434,177 |
| Higa Tomohiro | SVP, Finance | May 18 | Open-market sale · S | −1,485 | $0.79 | −$1.18K | 118,267 |
| Tingley Whittemore | Chief Medical Officer | May 18 | Open-market sale · S | −3,121 | $0.79 | −$2.48K | 215,497 |
| Ali Faraz | Chief Executive Officer | May 18 | Open-market sale · S | −3,390 | $0.79 | −$2.69K | 440,014 |
| Column Group Iii GP, Lp | 10% owner | Feb 25 | Open-market sale · S | −1,862,545 | $0.56 | −$1.05M | 0 |
| Column Group Iii GP, Lp | 10% owner | Feb 25 | Open-market sale · S | −1,649,281 | $0.56 | −$928K | 0 |
| Column Group Iii GP, Lp | 10% owner | Feb 24 | Open-market sale · S | −349,212 | $0.62 | −$215K | 1,862,545 |
| Column Group Iii GP, Lp | 10% owner | Feb 24 | Open-market sale · S | −309,228 | $0.62 | −$190K | 1,649,281 |
| Column Group Iii GP, Lp | 10% owner | Feb 23 | Open-market sale · S | −162,291 | $0.60 | −$96.9K | 2,211,757 |
| Column Group Iii GP, Lp | 10% owner | Feb 23 | Open-market sale · S | −143,709 | $0.60 | −$85.8K | 1,958,509 |
| Column Group Iii GP, Lp | 10% owner | Feb 20 | Open-market sale · S | −277,769 | $0.61 | −$171K | 2,374,048 |
Loading...